Article

Method of pacing does not affect the recurrence of syncope in carotid sinus syndrome.

Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA.
Pacing and Clinical Electrophysiology (Impact Factor: 1.75). 05/2012; 35(7):827-33. DOI:10.1111/j.1540-8159.2012.03375.x
Source: PubMed

ABSTRACT Pacemaker therapy is effective in reducing recurrent syncope in patients with symptomatic carotid sinus hypersensitivity (CSH), yet the optimal pacing modality for this syndrome is not known. The objective of this study is to prospectively investigate the impact of three pacing methods (DDDR vs DDDR with sudden bradycardia response [SBR] vs VVI) on recurrent syncope and quality of life.
Twenty-one patients with symptomatic CSH (syncope or near syncope) were randomized to VVI, DDDR, or DDDR with SBR on a double-blinded basis in a sequential crossover fashion with 6 months in each mode. The primary endpoints were recurrent events and quality of life (assessed by SF-36). The mean number of events and SF-36 scores were compared.
At baseline, over the preceding 6 months, there were a total of 29 syncopal events and 258 presyncopal events among 21 patients. Following pacing in any mode, the total number of these syncopal events reduced to two in two patients (P < 0.001) and 17 presyncopal events (P < 0.001) in 12 patients. The mean number of events was not significantly different between the three pacing methods. SF-36 scores revealed some minor benefits of DDDR pacing versus baseline in the categories, but no pacing method was found to be superior.
The study was unable to confirm the initial study hypothesis of a superiority of one pacing modality over another. Quality of life measures allude to potential benefit from DDDR pacing alone.

0 0
 · 
0 Bookmarks
 · 
76 Views
  • [show abstract] [hide abstract]
    ABSTRACT: In order to evaluate the diagnostic value of carotid sinus hypersensitivity (CSH) we have investigated 163 asymptomatic patients (88 male, 75 female, mean age 57.9 +/- 22.7 years) and 210 symptomatic patients (108 males, 102 females, mean age 61.1 +/- 28.1 years) with syncopes or dizziness. Thirty two of the 163 asymptomatic patients (20%) and 87 of the 210 symptomatic patients (41%) showed CSH (asystole greater than or equal to 3 sec during carotid sinus pressure). Male patients had a higher number of CSH than female (28% vs 10% in the asymptomatic group, 48% vs 34% in the symptomatic group). Electrophysiological investigations were performed in all 210 symptomatic patients. Normal electrophysiological results had 94 of the 210 patients. Thirty seven of these 94 patients showed CSH (39%). Prolonged sinus node recovery time (SNRT) and/or prolonged sinoatrial conduction time (SACT) were evaluated in 38 patients. Seventeen of the 38 patients had CSH (45%). Disorders of atrioventricular (AV) conduction were evaluated in 43 patients. Seventeen of the 43 patients showed CSH (40%). Thirty-five patients had both AV conduction disorders and prolonged SNRT or SACT. Sixteen of these 35 patients showed CSH (46%). In conclusion, no significant difference was found between patients with and without pathological electrophysiological results. The CSH is without value for predicting sinus node dysfunction and AV conduction disorder.
    Pacing and Clinical Electrophysiology 01/1991; 13(12 Pt 2):2065-70. · 1.75 Impact Factor
  • [show abstract] [hide abstract]
    ABSTRACT: The occurrence rate of spontaneous asystolic episodes during long-term follow-up in patients with abnormal asystolic responses induced by means of vasovagal maneuvers was evaluated. The heart rate of 23 patients (mean age 64 +/- 12 years; 6 women and 17 men) affected by neurally mediated syncope (mean 4.3 +/- 4.9 episodes) was continuously monitored by a specially designed implanted pacemaker able to detect and store in its memory all asystolic episodes lasting 3 to 6 or > 6 seconds. Asystolic, neurally mediated syncope was diagnosed when a reflex asystole of > 3 seconds was induced during carotid sinus massage (n = 22), eyeball compression test (n = 3) or head-up tilt test (n = 2). During a total of 357 months (mean 15 +/- 7) of monitoring, asystolic episodes occurred in 17 patients (74%): 1,765 episodes of 3- to 6-second (median 3) duration occurred in 14 patients, and 47 episodes of > 6-second (median 2) duration occurred in 11. The actuarial estimates of occurrence of asystolic episodes of > 3 and > 6 seconds were 82 and 53%, respectively, after 2 years of follow-up. Only 12 episodes of 3 to 6 seconds (0.7%), and 20 episodes of > 6 seconds (43%) resulted in presyncopal or syncopal symptoms. Thus, an asystolic response to vasovagal maneuvers predicts the occurrence of spontaneous asystolic episodes during follow-up. With few exceptions, spontaneous episodes are asymptomatic and their incidence is low.
    The American Journal of Cardiology 12/1993; 72(15):1152-5. · 3.21 Impact Factor
  • Source
    [show abstract] [hide abstract]
    ABSTRACT: A 36-item short-form (SF-36) was constructed to survey health status in the Medical Outcomes Study. The SF-36 was designed for use in clinical practice and research, health policy evaluations, and general population surveys. The SF-36 includes one multi-item scale that assesses eight health concepts: 1) limitations in physical activities because of health problems; 2) limitations in social activities because of physical or emotional problems; 3) limitations in usual role activities because of physical health problems; 4) bodily pain; 5) general mental health (psychological distress and well-being); 6) limitations in usual role activities because of emotional problems; 7) vitality (energy and fatigue); and 8) general health perceptions. The survey was constructed for self-administration by persons 14 years of age and older, and for administration by a trained interviewer in person or by telephone. The history of the development of the SF-36, the origin of specific items, and the logic underlying their selection are summarized. The content and features of the SF-36 are compared with the 20-item Medical Outcomes Study short-form.
    Medical Care 07/1992; 30(6):473-83. · 3.23 Impact Factor